PlainRecalls
FDA Drug Critical Class I Terminated

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reported: January 5, 2022 Initiated: December 3, 2021 #D-0299-2022

Product Description

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for Recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Details

Recalling Firm
Gilead Sciences, Inc.
Units Affected
53,473 vials
Distribution
Nationwide in the USA
Location
Foster City, CA

Frequently Asked Questions

What product was recalled?
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2. Recalled by Gilead Sciences, Inc.. Units affected: 53,473 vials.
Why was this product recalled?
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 5, 2022. Severity: Critical. Recall number: D-0299-2022.